Evidence map›Paper›PMID 41895101›Full record

Observational studyBrazilian journal of otorhinolaryngology

Prognostic factors analysis of patients with oral cavity squamous cell carcinoma.

Gustavo Mercuri, Isabella Grieger, Daniel Naves de Araújo, Fabio Lau, Carlos Takahiro Chone

Abstract readObservational Study
In one paragraph

Observational study in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gustavo MercuriUniversidade Estadual de Campinas (UNICAMP), Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, Campinas, SP, Brazil.
Isabella GriegerUniversidade Estadual de Campinas (UNICAMP), Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, Campinas, SP, Brazil.
Daniel Naves de AraújoUniversidade Estadual de Campinas (UNICAMP), Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, Campinas, SP, Brazil.
Fabio LauUniversidade Estadual de Campinas (UNICAMP), Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, Campinas, SP, Brazil.
Carlos Takahiro ChoneUniversidade Estadual de Campinas (UNICAMP), Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, Campinas, SP, Brazil. Electronic address: cchone@icloud.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to analyze prognostic factors associated with survival and recurrence in patients with Oral Cavity Squamous Cell Carcinoma (OCSCC) treated in São Paulo, Brazil. The investigation focused on evaluating the influence of clinical stage, treatment modality, age, and sex on overall and recurrence-free survival in a large cohort derived from a public cancer registry. STUDY

designSingle-center retrospective observational study with a cross-sectional and quantitative design.

settingSão Paulo, Brazil.

methodsA retrospective analysis was conducted using data from 10,122 patients diagnosed with OCSCC between 2004 and 2014, obtained from the Oncocenter Foundation of São Paulo (FOSP) database. The primary endpoint was Overall Survival (OS), and secondary endpoints included Recurrence-Free Survival (RFS), Disease-Free Survival (DFS), and Local Recurrence-Free Survival (LRFS). Prognostic factors were assessed through univariable and multivariable Cox proportional hazards models. Kaplan-Meier curves were used to estimate survival, and comparisons were made using the log-rank test.

resultsThe mean follow-up time was 39.37 ± 37.93 months. Age ranged from 11- to 104-years, with a mean age of 60.2 ± 12.6 years at diagnosis, and 78.3% were male. Most patients (61.97%) were diagnosed at an advanced stage (III-IV). Advanced stage and non-surgical treatment were independently associated with worse OS (HR = 4.253, 95% CI 3.883-4.659; 2.546, 95% CI 2.381-2.722, respectively). The 5-year overall survival rate was 50.3%, with a mean survival interval of 6.70 ± 0.06 years after diagnosis. Elderly patients and men had higher recurrence and mortality risks, whereas early-stage disease and surgical treatment were associated with better outcomes.

conclusionAdvanced clinical stage and non-surgical treatment were the strongest independent prognostic factors for decreased survival in OSCC. These findings underscore the importance of early detection and surgical management, as well as the need for public health strategies to reduce diagnostic and treatment delays in Brazil. LEVEL OF EVIDENCE: 2B.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsAdolescentAdultAgedAged, 80 and overAge FactorsBrazilChildCross-Sectional StudiesDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateMaleMiddle AgedOral cancerOral cavity neoplasmOral cavity squamous cell carcinomaSurvival analysis

Identifiers

PMID41895101
PMCPMC13058958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.